All In Biotech

Drug Trial Radar · NCT05898399

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

A Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of the DNA Polymerase Theta Inhibitor ART6043 Administered Orally as Monotherapy and in Combination to Patients With Advanced or Metastatic Solid Tumors

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 181 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

181

Planned (sponsor's estimate)

Start

Jun 30, 2023

Primary completion

Jun 30, 2028

Study completion Sep 30, 2028

Sponsor

Lead sponsor
Artios Pharma LtdIndustry
Sponsor type
Industry
First posted
Jun 12, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This interventional study will evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of ART6043 as monotherapy or in combination with olaparib.

Conditions

  • Advanced Solid Tumor
  • Metastatic Solid Tumor

Interventions

  • ART6043Drug

    ART6043 will be given orally.

  • OlaparibDrug

    Olaparib will be given orally.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Number of participants with Dose Limiting Toxicities (DLTs)Time frame: From first dose of study treatment until the end of Cycle 1 (each cycle is 21-days)
  2. Part B2: Progression free survival (PFS)Time frame: Until disease progression (Upto 3.7 years).

Locations

27 sites in 3 countries. Site status is shown where the registry gives one.

  • South Texas Accelerated Research Therapeutics (START) - Midwest

    Grand Rapids, Michigan · Active not recruiting

  • Memorial Sloan-Kettering Cancer Center (MSKCC)

    New York, New York · Active not recruiting

  • Stephenson Cancer Center - Oncology

    Oklahoma City, Oklahoma · Active not recruiting

  • Jefferson University Hospitals - Kimmel Cancer Center

    Philadelphia, Pennsylvania · Active not recruiting

  • SCRI oncology partners

    Nashville, Tennessee · Completed

  • Mary Crowley Cancer Center - Clinic

    Dallas, Texas · Completed

  • The University of Texas - MD Anderson Cancer Center

    Houston, Texas · Active not recruiting

  • Complejo Hospitalario Universitario A Coruña CHUAC

    A Coruña, Spain · Recruiting

  • Instituto Valenciano de Oncologia-IVO

    Bàguena, Spain · Recruiting

  • Hospital Universitario de Jerez de la Frontera

    Cadiz, Spain · Recruiting

  • Hospital Universitario de Canarias

    Canara, Spain · Recruiting

  • Hospital Universitario de Jaen

    Jaén, Spain · Recruiting

  • Hospital General Universitario Gregorio Marañon

    Madrid, Spain · Recruiting

  • Hospital Universitario Virgen de la Victoria

    Málaga, Spain · Recruiting

  • Hospital Clinico Universitario Virgen de la Arrixaca

    Murcia, Spain · Recruiting

  • Hospital Universitario Virgen del Rocio

    Seville, Spain · Recruiting

  • Hospital Universitario Virgen Macarena

    Seville, Spain · Recruiting

  • Hospital Clinico Universitario de Valencia

    Valencia, Spain · Recruiting

  • Hospital Clinico Universitario Lozano Blesa

    Zaragoza, Spain · Recruiting

  • Hospital Universitario Clínico San Cecilio

    Granada, Andalusia, Spain · Recruiting

  • Hospital Clínico Universitario de Valladolid

    Valladolid, Castille and León, Spain · Recruiting

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, Catalonia, Spain · Recruiting

  • Hospital San Pedro de Alcántara

    Cáceres, Extremadura, Spain · Recruiting

  • Hospital Universitario 12 de Octubre

    Madrid, Madrid, Spain · Recruiting

  • Hospital Clinico San Carlos

    San Carlos, Madrid, Spain · Recruiting

  • University College London

    London, United Kingdom · Recruiting

  • The Christie

    Manchester, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.